UCB - Equity Capital And Reserves


UCB reported EUR10.87B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alcon AG USD 22.13B 99M Mar/2026
Almirall EUR 1.53B 43.26M Jun/2026
Amarin USD 443.62M 5.8M Jun/2026
argenx SE USD 8.42B 1.09B Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 41.95B 3.02B Jun/2026
Orion EUR 1.27B 146.5M Jun/2026
Recordati EUR 2.13B 70.34M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
UCB EUR 10.87B 1.18B Dec/2025
Unibail Rodamco EUR 15.9B 559M Dec/2025